肾内科指南

订阅

MedSci主页 / 所有栏目 / 肾内科指南

2017年KDIGO活体肾脏移植供者评估医疗的临床实践指南解读

2017-09-30 中国循证医学杂志.2017,17(9):1005-1010.

活体供肾

肾脏移植是治疗终末期肾病（end stage kidney disease，ESKD）的最佳方式，供肾匮乏是当前移植界面临的最大问题。活体肾移植是解决供肾缺乏的重要手段，同时因其具有移植效果优于尸体肾移植等优势而在全世界广泛开展。活体肾移植是一种特殊类型的医疗实践，是为了挽救别人生命而让一个健康供者接受手术及由此带来的短长期风险。因此，如何最大程度的保障供者利益是医学界和法律界最为关注的问题。为帮

中文标题：

2017年KDIGO活体肾脏移植供者评估医疗的临床实践指南解读

发布机构：

发布日期：

2017-09-30

简要介绍：

肾脏移植是治疗终末期肾病（end stage kidney disease，ESKD）的最佳方式，供肾匮乏是当前移植界面临的最大问题。活体肾移植是解决供肾缺乏的重要手段，同时因其具有移植效果优于尸体肾移植等优势而在全世界广泛开展。活体肾移植是一种特殊类型的医疗实践，是为了挽救别人生命而让一个健康供者接受手术及由此带来的短长期风险。因此，如何最大程度的保障供者利益是医学界和法律界最为关注的问题。为帮助医务工作者评估意向供者及改进对供者术前、术中和术后关怀，全球肾脏病预后组织（kidney disease：improving global outcomes，KDIGO）于 2017 年 8 月颁布了该组织首个活体肾移植供者评估关怀的临床指南。本文对该指南的重点部分进行解读。

作者： 四川大学华西医院泌尿外科 林涛

 

拓展指南：与肾移植相关指南：

相关资料下载：
[AttachmentFileName(sort=100, fileName=2017年KDIGO活体肾脏移植供者评估医疗的临床实践指南解读)] GetToolGuiderByIdResponse(projectId=1, id=598d61c00151357d, title=2017年KDIGO活体肾脏移植供者评估医疗的临床实践指南解读, enTitle=, guiderFrom=中国循证医学杂志.2017,17(9):1005-1010., authorId=null, author=, summary=肾脏移植是治疗终末期肾病（end stage kidney disease，ESKD）的最佳方式，供肾匮乏是当前移植界面临的最大问题。活体肾移植是解决供肾缺乏的重要手段，同时因其具有移植效果优于尸体肾移植等优势而在全世界广泛开展。活体肾移植是一种特殊类型的医疗实践，是为了挽救别人生命而让一个健康供者接受手术及由此带来的短长期风险。因此，如何最大程度的保障供者利益是医学界和法律界最为关注的问题。为帮, cover=, journalId=null, articlesId=null, associationId=null, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Sat Sep 30 00:00:00 CST 2017, originalUrl=, linkOutUrl=, content=<P>肾脏移植是治疗终末期肾病（end stage kidney disease，ESKD）的最佳方式，供肾匮乏是当前移植界面临的最大问题。活体肾移植是解决供肾缺乏的重要手段，同时因其具有移植效果优于尸体肾移植等优势而在全世界广泛开展。活体肾移植是一种特殊类型的医疗实践，是为了挽救别人生命而让一个健康供者接受手术及由此带来的短长期风险。因此，如何最大程度的保障供者利益是医学界和法律界最为关注的问题。为帮助医务工作者评估意向供者及改进对供者术前、术中和术后关怀，全球肾脏病预后组织（kidney disease：improving global outcomes，KDIGO）于 2017 年 8 月颁布了该组织首个活体肾移植供者评估关怀的临床指南。本文对该指南的重点部分进行解读。 </P>作者： 四川大学华西医院泌尿外科 林涛 <P> </P>拓展指南：<strong>与<font color=red>肾移植</font>相关指南：</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=cdc741c00150503b" title="中国肾移植受者哺乳动物雷帕霉素靶蛋白抑制剂临床应用专家共识" target=_blank>中国肾移植受者哺乳动物雷帕霉素靶蛋白抑制剂临床应用专家共识</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=e0bff1c001a6818c" title="2017 EAU指南：肾移植" target=_blank>2017 EAU指南：肾移植</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=23a281c001a2212d" title="2017 RA临床实践指南：肾移植受者术后护理" target=_blank>2017 RA临床实践指南：肾移植受者术后护理</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=615481c0013120fa" title="2016 中国活体供肾移植临床指南" target=_blank>2016 中国活体供肾移植临床指南</a></li> <li><a href="http://www.medsci.cn/guideline/show_article.do?id=3b5a01c0012a56d2" title="2016 中国肾移植排斥反应临床诊疗指南" target=_blank>2016 中国肾移植排斥反应临床诊疗指南</a></li> 更多信息请点击：<a href="http://www.medsci.cn/guideline/list.do?q=%E8%82%BE%E7%A7%BB%E6%A4%8D" target=_blank>有关肾移植更多指南</a></ul>, tagList=[TagDto(tagId=101415, tagName=活体供肾)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=解读, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4863, appHits=133, showAppHits=0, pcHits=3800, showPcHits=1347, likes=118, shares=4, comments=8, approvalStatus=1, publishedTime=Mon Oct 30 22:22:42 CST 2017, publishedTimeString=2017-09-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Mon Oct 30 22:22:42 CST 2017, updatedBy=null, updatedName=null, updatedTime=Fri Jan 05 08:53:51 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017年KDIGO活体肾脏移植供者评估医疗的临床实践指南解读)])
2017年KDIGO活体肾脏移植供者评估医疗的临床实践指南解读
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=257814, encodeId=c06125e8147b, content=非常好学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Wed Nov 01 15:52:44 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257595, encodeId=386125e595c0, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 31 22:00:57 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257436, encodeId=79c825e43654, content=不错的.学习了.学习分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Oct 31 07:43:12 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257404, encodeId=e43f25e404ce, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Oct 31 07:14:55 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257373, encodeId=c27a25e37304, content=非常好.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Tue Oct 31 05:38:28 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-11-01 swfzhanggui

    非常好学习了.谢谢分享

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=257814, encodeId=c06125e8147b, content=非常好学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Wed Nov 01 15:52:44 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257595, encodeId=386125e595c0, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 31 22:00:57 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257436, encodeId=79c825e43654, content=不错的.学习了.学习分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Oct 31 07:43:12 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257404, encodeId=e43f25e404ce, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Oct 31 07:14:55 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257373, encodeId=c27a25e37304, content=非常好.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Tue Oct 31 05:38:28 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-10-31 惠映实验室

    学习了.谢谢

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=257814, encodeId=c06125e8147b, content=非常好学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Wed Nov 01 15:52:44 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257595, encodeId=386125e595c0, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 31 22:00:57 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257436, encodeId=79c825e43654, content=不错的.学习了.学习分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Oct 31 07:43:12 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257404, encodeId=e43f25e404ce, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Oct 31 07:14:55 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257373, encodeId=c27a25e37304, content=非常好.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Tue Oct 31 05:38:28 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-10-31 中医痴

    不错的.学习了.学习分享!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=257814, encodeId=c06125e8147b, content=非常好学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Wed Nov 01 15:52:44 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257595, encodeId=386125e595c0, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 31 22:00:57 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257436, encodeId=79c825e43654, content=不错的.学习了.学习分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Oct 31 07:43:12 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257404, encodeId=e43f25e404ce, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Oct 31 07:14:55 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257373, encodeId=c27a25e37304, content=非常好.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Tue Oct 31 05:38:28 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-10-31 明月清辉

    谢谢分享.学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=257814, encodeId=c06125e8147b, content=非常好学习了.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Wed Nov 01 15:52:44 CST 2017, time=2017-11-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257595, encodeId=386125e595c0, content=学习了.谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Tue Oct 31 22:00:57 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257436, encodeId=79c825e43654, content=不错的.学习了.学习分享!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdqKgfW3nMpOkC3jXxiaW2po0PtglY5ZuVjERqKADW4HyMI8bcZXWlKgH7tEP9ULBoBzuQMibia4pr1s9rQPqLvqQJ/0, createdBy=e8c02060444, createdName=中医痴, createdTime=Tue Oct 31 07:43:12 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257404, encodeId=e43f25e404ce, content=谢谢分享.学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=88, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Tue Oct 31 07:14:55 CST 2017, time=2017-10-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=257373, encodeId=c27a25e37304, content=非常好.谢谢分享, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/10/21/9461f3b3c9f14e1d844256cdd08f2cf3.jpg, createdBy=a30f1426910, createdName=swfzhanggui, createdTime=Tue Oct 31 05:38:28 CST 2017, time=2017-10-31, status=1, ipAttribution=)]
    2017-10-31 swfzhanggui

    非常好.谢谢分享

    0